首页 | 本学科首页   官方微博 | 高级检索  
     

阿那曲唑单药或联合吉非替尼用于早期乳腺癌新辅助治疗的比较
引用本文:江泽飞,张国淳. 阿那曲唑单药或联合吉非替尼用于早期乳腺癌新辅助治疗的比较[J]. 循证医学, 2008, 8(3): 138-139. DOI: 10.3969/j.issn.1671-5144.2008.03.004
作者姓名:江泽飞  张国淳
作者单位:1. 军事医学科学院307医院乳腺癌科, 北京,100071;2. 广东省人民医院肿瘤中心乳腺科, 广州,510080
摘    要:1 文献来源A phase Ⅱ placebo—controlled trial of neoadjuvant Anastrozole alone or with Gefitinib in early breast cancer[J].J Clin Oncol,2007,25(25):3816—3822.

关 键 词:乳腺肿瘤  Ⅱ期临床试验  安慰剂对照  新辅助  内分泌治疗  芳香化酶抑制剂  酪氨酸激酶抑制剂

A Phase Ⅱ Placebo-Controlled Trial of Neoadjuvant Anastrozole Alone or with Geflflnib in Early Breast Cancer
JIANG Ze-fei,ZHANG Guo-chun. A Phase Ⅱ Placebo-Controlled Trial of Neoadjuvant Anastrozole Alone or with Geflflnib in Early Breast Cancer[J]. The Journal of Evidence-Based Medicine, 2008, 8(3): 138-139. DOI: 10.3969/j.issn.1671-5144.2008.03.004
Authors:JIANG Ze-fei  ZHANG Guo-chun
Affiliation:Reviewer: JIANG Ze-fei1,Literature Co-worker: ZHANG Guo-chun2 Department of Breast Cancer,307 Hospital of Academy of Military Medical Sciences,Beijing 100071,China
Abstract:1文献来源 A phase Ⅱ placebo-controlled trial of neoadjuvant Anastrozole alone or with Gefitinib in early breast cancer[J].J Clin Oncol,2007,25(25):3816-3822.
Keywords:breast neoplasms  phase Ⅱ clinical trial  placebocontrolled  neoadjuvant endocrine therapy  aromatase inhibitor  tyrosine kinase inhibitor
本文献已被 CNKI 维普 万方数据 等数据库收录!
点击此处可从《循证医学》浏览原始摘要信息
点击此处可从《循证医学》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号